Targeting cancer stemness mediated by <scp>BMI1</scp> and <scp>MCL1</scp> for non‐small cell lung cancer treatment-Reference-Cited by-同舟云学术

Targeting cancer stemness mediated by BMI1 and MCL1 for non‐small cell lung cancer treatment

Published:2022-07-06 Issue:15 Volume:26 Page:4305-4321
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cellular Molecular Medi

Author:

Lin Erh‐Hsuan¹²³⁴,Hsu Jhen‐Wei¹²,Lee Ting‐Fang³,Hsu Chiung‐Fang¹,Lin Tsung‐Hsien²³⁴,Jan Yi‐Hua⁵,Chang Hsiang‐Yi²³⁴,Cheng Chun‐Ming⁶,Hsu Hui‐Jan⁷,Chen Wei‐Wei⁶,Chen Bo‐Hung³,Tsai Hsing‐Fang⁵,Li Jung‐Jung²³⁴,Huang Chi‐Ying⁸^ORCID,Chuang Shih‐Hsien⁷,Chang Jia‐Ming⁶,Hsiao Michael⁵^ORCID,Wu Cheng‐Wen¹²³⁴^ORCID

Affiliation:

1. Institute of Biomedical Sciences Academia Sinica Taipei Taiwan

2. Institute of Microbiology and Immunology National Yang Ming Chiao Tung University Taipei Taiwan

3. Institute of Clinical Medicine National Yang Ming Chiao Tung University Taipei Taiwan

4. Institute of Biochemistry and Molecular Biology National Yang Ming Chiao Tung University Taipei Taiwan

5. Genomics Research Center Academia Sinica Taipei Taiwan

6. Department of Pharmacology, Development Center for Biotechnology Institute for Drug Evaluation Platform Taipei Taiwan

7. Department of Medicinal Chemistry, Development Center for Biotechnology Institute of Pharmaceutics Taipei Taiwan

8. Institute of Biopharmaceutical Sciences National Yang Ming Chiao Tung University Taipei Taiwan

Funder

Ministry of Science and Technology, Taiwan

National Yang-Ming University

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.17453

Reference51 articles.

1. ASCO_Cancer.net. Lung Cancer ‐ Non‐Small Cell: Statistics.2018. Accessed February 2022.https://wwwcancernet/cancer‐types/lung‐cancer‐non‐small‐cell/statistics

2. Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC

3. Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance

4. Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells

5. Cancer stem cells revisited

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of E3 ligases in lung cancer;Biochemistry and Biophysics Reports;2024-07

2. SOX4-BMI1 Axis Promotes Non-Small Cell Lung Cancer Progression and Facilitates Angiogenesis by Suppressing ZNF24;2024-06-10

3. Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer;BMC Complementary Medicine and Therapies;2024-02-01

4. Exosomal hsa-miR-151a-3p and hsa-miR-877-5p are potential novel biomarkers for predicting bone metastasis in lung cancer;Aging;2023-12-18

5. Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review;Cancer Cell International;2023-11-20